Full Text View
Tabular View
No Study Results Posted
Related Studies
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
This study is currently recruiting participants.
Verified November 2011 by Retina Vitreous Associates of Florida
Study NCT01476449   Information provided by Retina Vitreous Associates of Florida

First Received on November 13, 2011.   Last Updated on July 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Retinopathy
Macular Edema
Additional conditions recognized in this trial
Edema
Retinal Diseases
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Diabetic Angiopathies
Endocrine System Diseases
Eye Diseases
Macular Degeneration
Retinal Degeneration
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Ranibizumab
Sponsors listed in this trial
Retina Vitreous Associates of Florida
Genentech


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services